EyePoint Pharmaceuticals, Inc. financial data

Symbol
EYPT on Nasdaq
Industry
Laboratory Analytical Instruments
Location
480 Pleasant Street, Suite B300, Watertown, MA
State of incorporation
Delaware
Fiscal year end
December 31
Former names
pSivida Corp. (to 3/30/2018), pSivida LTD (to 6/18/2008)
Latest financial report
10-Q - Q2 2024 - Aug 8, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 440 % +6.99%
Quick Ratio 6.52 % -27.1%
Debt-to-equity 45.5 % -53.8%
Return On Equity -43.2 % +62.4%
Return On Assets -29.7 % +48.7%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 53.5M shares +53%
Common Stock, Shares, Outstanding 52.2M shares +52%
Entity Public Float 233M USD +11.2%
Common Stock, Value, Issued 52K USD +52.9%
Weighted Average Number of Shares Outstanding, Basic 53.2M shares +41.6%
Weighted Average Number of Shares Outstanding, Diluted 53.2M shares +41.6%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax 50.4M USD +35%
Research and Development Expense 95.3M USD +70%
Selling and Marketing Expense 6.71M USD -70.8%
General and Administrative Expense 48.7M USD +35.1%
Costs and Expenses 44M USD +38.2%
Operating Income (Loss) -98.6M USD +7.36%
Nonoperating Income (Expense) 11.9M USD +2295%
Net Income (Loss) Attributable to Parent -86.8M USD +18.1%
Earnings Per Share, Basic -1.78 USD/shares +37.1%
Earnings Per Share, Diluted -1.78 USD/shares +37.1%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 90.8M USD -35%
Marketable Securities, Current 189M USD +6349%
Cash, Cash Equivalents, and Short-term Investments 280M USD +96.6%
Inventory, Net 3.67M USD -13.8%
Other Assets, Current 1.07M USD
Assets, Current 295M USD +76.5%
Property, Plant and Equipment, Net 6.9M USD +140%
Operating Lease, Right-of-Use Asset 22.3M USD +304%
Assets 324M USD +84.6%
Accounts Payable, Current 14.3M USD +33.4%
Employee-related Liabilities, Current 6.99M USD +11.5%
Accrued Liabilities, Current 13.3M USD -11.9%
Liabilities, Current 62.1M USD -9.89%
Operating Lease, Liability, Noncurrent 22.2M USD +306%
Other Liabilities, Noncurrent 0 USD -100%
Liabilities 95.9M USD -19%
Accumulated Other Comprehensive Income (Loss), Net of Tax 792K USD -5.94%
Retained Earnings (Accumulated Deficit) -802M USD -12.1%
Stockholders' Equity Attributable to Parent 228M USD +299%
Liabilities and Equity 324M USD +84.6%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -31.2M USD -85.2%
Net Cash Provided by (Used in) Financing Activities 115K USD
Net Cash Provided by (Used in) Investing Activities 20.8M USD -35.2%
Common Stock, Shares Authorized 300M shares 0%
Common Stock, Shares, Issued 52.2M shares +52%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -10.3M USD -201%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 90.9M USD -34.9%
Interest Paid, Excluding Capitalized Interest, Operating Activities 0 USD -100%
Deferred Tax Assets, Valuation Allowance 146M USD +17.3%
Deferred Tax Assets, Gross 148M USD +16.9%
Operating Lease, Liability 23.3M USD +263%
Depreciation 303K USD +189%
Payments to Acquire Property, Plant, and Equipment 1.19M USD +147%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -86.9M USD +17.8%
Lessee, Operating Lease, Liability, to be Paid 48.6M USD +555%
Property, Plant and Equipment, Gross 7.82M USD +126%
Operating Lease, Liability, Current 1.13M USD +16.5%
Lessee, Operating Lease, Liability, to be Paid, Year Two 4.14M USD +177%
Lessee, Operating Lease, Liability, to be Paid, Year One 3.79M USD +173%
Operating Lease, Weighted Average Discount Rate, Percent 0.12 pure +103%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 25.3M USD +2431%
Lessee, Operating Lease, Liability, to be Paid, Year Three 4.23M USD +166%
Deferred Tax Assets, Operating Loss Carryforwards 82.6M USD -6.76%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 5M shares 0%
Unrecognized Tax Benefits 0 USD
Lessee, Operating Lease, Liability, to be Paid, Year Four 3.32M USD +103%
Operating Lease, Payments 274K USD +67.1%
Preferred Stock, Shares Outstanding 0 shares
Amortization of Intangible Assets 0 USD -100%
Share-based Payment Arrangement, Expense 28.6M USD +151%
Interest Expense 0 USD -100%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%